Gentian Diagnostics ASA
OSE:GENT

Watchlist Manager

Gentian Diagnostics ASA

OSE:GENT

Watchlist

Dividends

Price: 43.6 NOK -1.36% Market Closed

Market Cap: 672.4m NOK

Have any thoughts about
Gentian Diagnostics ASA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Fubotv Inc NYSE:FUBO	Media
US	Bank of America Corp NYSE:BAC	Banking
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Uber Technologies Inc NYSE:UBER	Road & Rail
CN	NIO Inc NYSE:NIO	Automobiles
US	Fluor Corp NYSE:FLR	Construction
US	Jacobs Engineering Group Inc NYSE:J	Professional Services
US	TopBuild Corp NYSE:BLD	Consumer products
US	Abbott Laboratories NYSE:ABT	Health Care
US	Chevron Corp NYSE:CVX	Energy
US	Occidental Petroleum Corp NYSE:OXY	Energy
US	Matrix Service Co NASDAQ:MTRX	Construction
US	Automatic Data Processing Inc NASDAQ:ADP	Technology
US	Qualcomm Inc NASDAQ:QCOM	Semiconductors
US	PayPal Holdings Inc NASDAQ:PYPL	Technology
US	Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 43.6 NOK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

GENT Alert

Gentian Diagnostics ASA

43.6

-0.6 (-1.36%)

52 Week Range	35.8 59
Price Target

We'll email you a reminder when the closing price reaches NOK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	PayPal Holdings Inc NASDAQ:PYPL	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Gentian Diagnostics ASA

What unique competitive advantages
does Gentian Diagnostics ASA hold over its rivals?

What risks and challenges
does Gentian Diagnostics ASA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Gentian Diagnostics ASA.

What unique competitive advantages
does Gentian Diagnostics ASA hold over its rivals?

What risks and challenges
does Gentian Diagnostics ASA face in the near future?

Summarize the latest earnings call
of Gentian Diagnostics ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Gentian Diagnostics ASA.

Provide P/S
for Gentian Diagnostics ASA.

Provide P/E
for Gentian Diagnostics ASA.

Provide P/OCF
for Gentian Diagnostics ASA.

Provide P/FCFE
for Gentian Diagnostics ASA.

Provide P/B
for Gentian Diagnostics ASA.

Provide EV/S
for Gentian Diagnostics ASA.

Provide EV/GP
for Gentian Diagnostics ASA.

Provide EV/EBITDA
for Gentian Diagnostics ASA.

Provide EV/EBIT
for Gentian Diagnostics ASA.

Provide EV/OCF
for Gentian Diagnostics ASA.

Provide EV/FCFF
for Gentian Diagnostics ASA.

Provide EV/IC
for Gentian Diagnostics ASA.

Show me price targets
for Gentian Diagnostics ASA made by professional analysts.

What are the Revenue projections
for Gentian Diagnostics ASA?

How accurate were the past Revenue estimates
for Gentian Diagnostics ASA?

What are the Net Income projections
for Gentian Diagnostics ASA?

How accurate were the past Net Income estimates
for Gentian Diagnostics ASA?

What are the EPS projections
for Gentian Diagnostics ASA?

How accurate were the past EPS estimates
for Gentian Diagnostics ASA?

What are the EBIT projections
for Gentian Diagnostics ASA?

How accurate were the past EBIT estimates
for Gentian Diagnostics ASA?

Compare the revenue forecasts
for Gentian Diagnostics ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Gentian Diagnostics ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Gentian Diagnostics ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Gentian Diagnostics ASA compared to its peers.

Compare the P/E ratios
of Gentian Diagnostics ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Gentian Diagnostics ASA with its peers.

Analyze the financial leverage
of Gentian Diagnostics ASA compared to its main competitors.

Show all profitability ratios
for Gentian Diagnostics ASA.

Provide ROE
for Gentian Diagnostics ASA.

Provide ROA
for Gentian Diagnostics ASA.

Provide ROIC
for Gentian Diagnostics ASA.

Provide ROCE
for Gentian Diagnostics ASA.

Provide Gross Margin
for Gentian Diagnostics ASA.

Provide Operating Margin
for Gentian Diagnostics ASA.

Provide Net Margin
for Gentian Diagnostics ASA.

Provide FCF Margin
for Gentian Diagnostics ASA.

Show all solvency ratios
for Gentian Diagnostics ASA.

Provide D/E Ratio
for Gentian Diagnostics ASA.

Provide D/A Ratio
for Gentian Diagnostics ASA.

Provide Interest Coverage Ratio
for Gentian Diagnostics ASA.

Provide Altman Z-Score Ratio
for Gentian Diagnostics ASA.

Provide Quick Ratio
for Gentian Diagnostics ASA.

Provide Current Ratio
for Gentian Diagnostics ASA.

Provide Cash Ratio
for Gentian Diagnostics ASA.

What is the historical Revenue growth
over the last 5 years for Gentian Diagnostics ASA?

What is the historical Net Income growth
over the last 5 years for Gentian Diagnostics ASA?

What is the current Free Cash Flow
of Gentian Diagnostics ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Gentian Diagnostics ASA.

EV/S
Enterprise Value to Sales

4.1

Current

5.6

Median

2.4

Industry

Lower than median

Higher than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S

4.1

Enterprise Value

596.1m NOK

Revenue

146.3m NOK

All Countries

Forward Multiples

			Market Cap	EV/S
NO	G	Gentian Diagnostics ASA OSE:GENT	669.3m NOK	4.1
JP		Hoya Corp TSE:7741	7.2T JPY	8.4
CH		Alcon AG SIX:ALC	39.2B CHF	5.1
DK		Coloplast A/S CSE:COLO B	193.5B DKK	5.3
US		Align Technology Inc NASDAQ:ALGN	15.4B USD	3.6
CN		Shenzhen New Industries Biomedical Engineering Co Ltd SZSE:300832	53.8B CNY	11.9
US		Lantheus Holdings Inc NASDAQ:LNTH	7.6B USD	5.2
CA		Bausch + Lomb Corp NYSE:BLCO	7.1B USD	2.5
KR	H	HLB Inc KOSDAQ:028300	8.6T KRW	192.3
CH		Ypsomed Holding AG SIX:YPSN	5.3B CHF	10
US		Merit Medical Systems Inc NASDAQ:MMSI	5.8B USD	4.6


NO	G	Gentian Diagnostics ASA OSE:GENT	Average EV/S: 23 4.1
JP		Hoya Corp TSE:7741	8.4
CH		Alcon AG SIX:ALC	5.1
DK		Coloplast A/S CSE:COLO B	5.3
US		Align Technology Inc NASDAQ:ALGN	3.6
CN		Shenzhen New Industries Biomedical Engineering Co Ltd SZSE:300832	11.9
US		Lantheus Holdings Inc NASDAQ:LNTH	5.2
CA		Bausch + Lomb Corp NYSE:BLCO	2.5
KR	H	HLB Inc KOSDAQ:028300	192.3
CH		Ypsomed Holding AG SIX:YPSN	10
US		Merit Medical Systems Inc NASDAQ:MMSI	4.6

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/S

3.5

2-Years Forward

EV/S

2.6

3-Years Forward

EV/S

N/A

Gentian Diagnostics ASA
OSE:GENT

EV/S
Enterprise Value to Sales

EV/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Gentian Diagnostics ASA OSE:GENT

EV/S Enterprise Value to Sales

EV/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Gentian Diagnostics ASA
OSE:GENT

EV/S
Enterprise Value to Sales